Loading…

Thermo Fisher Scientific (TMO) backlog: remaining performance obligations

How much revenue Thermo Fisher Scientific already has under contract, how fast it converts, and who it is with.

Data as of .

Thermo Fisher Scientific backlog history

$0$20B$40BDec 2022ul 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2026Sep 2026Backlog (RPO)Trailing 12-month revenue
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter endBacklog (RPO)TTM revenueCoverageCustomer prepayments
26 Sep 2026$29.9B$47.4B0.6 yrs$2.94B
27 Jun 2026$29.7B$46.3B0.6 yrs$2.92B
28 Mar 2026$29.4B$45.2B0.7 yrs$2.93B
31 Dec 2025$27.9B$44.6B0.6 yrs$2.71B
27 Sep 2025$26.5B$43.7B0.6 yrs$2.85B
28 Jun 2025$25.0B$43.2B0.6 yrs$2.81B
29 Mar 2025$24.5B$42.9B0.6 yrs$2.87B
31 Dec 2024$24.6B$42.9B0.6 yrs$2.85B
28 Sep 2024$25.3B$42.4B0.6 yrs$2.66B
29 Jun 2024$25.9B$42.3B0.6 yrs$2.59B
30 Mar 2024$26.4B$42.5B0.6 yrs$2.63B
31 Dec 2023$26.9B$42.9B0.6 yrs$2.69B

Questions

What is Thermo Fisher Scientific's backlog?
Thermo Fisher Scientific reported $29.9B of remaining performance obligations at 26 Sep 2026, up 13% from a year earlier and up 1% from the previous quarter. That is 0.6 years of trailing revenue already under contract. Book-to-bill last quarter: 1.01.
How fast does Thermo Fisher Scientific's backlog turn into revenue?
Over the last twelve months Thermo Fisher Scientific recognised revenue equal to about 167% of the backlog it started each quarter with.

About these numbers

Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.